Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Flt-3 Ligand, ACFP Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Applications: Bioactivity
Supplier: R&D Systems™ ACFP308
This item is not returnable.
View return policy
Description
The Recombinant Human Flt-3 Ligand, ACFP Protein is derived from Sf 9 (baculovirus). The Recombinant Human Flt-3 Ligand, ACFP Protein has been validated for the following applications: Bioactivity.Specifications
AAA17999.1 | |
2323 | |
50 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution. | |
<0.01 EU per 1 μg of the protein by the LAL method. | |
FLT3LG | |
Unconjugated | |
Recombinant | |
Lyophilized from a 0.2 μm filtered solution in PBS. |
Bioactivity | |
17.5 kDa | |
Spodoptera frugiperda,Sf 9 (baculovirus)-derived human Flt-3 Ligand/FLT3L protein Thr27-Pro184 Produced in an animal component free process (ACFP). | |
RUO | |
FL, FLG3L, Flt3 ligand, Flt3L, FLT3LG, fms-related tyrosine kinase 3 ligand, SL cytokine | |
Flt-3 Ligand | |
Human | |
Reconstitute at 100 μg/mL in PBS. | |
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction